Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
Authors
Thatcher, NickGirling, David J
Hopwood, Penelope
Sambrook, Robert J
Qian, Wendi
Stephens, Richard J
Affiliation
Cancer Division, Medical Research Council Clinical Trials Unit, London, United Kingdom.Issue Date
2000-01